Mutations in human Adenomatous Polyposis Coli (APC) gene are associated wit
h both familial and sporadic colorectal tumors. APC is known to down regula
te beta -catenin levels, a transducer of Wnt signaling. The aim of this stu
dy is to provide transgenic Drosophila expressing either full-length or tru
ncated forms of human APC (hAPC) protein and methods for using them in func
tional,genomics and drug screening. Consistent with its biochemical propert
ies, targeted expression of either full-length hAPC or its beta -catenin bi
nding domain alone negatively regulated the function of the beta -catenin h
omologue, Armadillo (Arm) and thereby, inhibited Wnt/Wg signaling during fl
y development. hAPC inhibited Arm function even in the absence of GSK-3 bet
a activity, although the latter was required to mediate the degradation of
Arm. Consistent with this, hAPC suppressed the phenotypes induced by the ov
er-expression of degradation-resistant forms of Arm. Subsequently, using hA
PC-induced eye phenotypes as the assay in a suppressor-enhancer screen, we
have identified two new loci in Drosophila, which modulate Wnt/Wg signaling
. In addition, an anti-colon cancer drug, indomethacin, specifically enhanc
ed hAPC-induced phenotypes.